Taken together with our findings of S100A4 overexpression in advanced thyroid tumours, the transgenic mouse model may fit well with human PTC, implicating that S100A4 may enhance thyroid cancer invasion and metastasis in cooperation with c-erbB-2/neu. Here, S100A4 is linked to thyroid gland carcinoma.